"Ozempic feet" and "Ozempic mouth" are the latest reported cosmetic side effects from GLP-1 medications used for weight loss.

GLP-1 drugs like Ozempic, Mounjaro, Zepbound, originally for adults, are now prescribed for adolescents with obesity, showing ...

After going after the companies making compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were previously selling the copycats.

Ozempic has its own positive cardiovascular outcomes trial in hand – called SUSTAIN 6 – which included type 2 diabetics with established cardiovascular disease or kidney disease as well as ...

Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic ...

Mounfit addresses one of the biggest reasons weight loss efforts fail-appetite dysregulation. It does this by incorporating ...

Does vitamin D deficiency cause hair loss? Learn the connection between these two and how maintaining adequate levels may prevent hair loss.

It is also used to lower the risk of major heart events in people with both type 2 diabetes and heart disease, such as stroke, heart attack, or death due to heart disease. Note that Ozempic is not FDA ...

Invokanna (also known as canagliflozin) is a third SGLT2 inhibitor that is FDA-approved to treat chronic kidney disease. And now the GLP1-receptor agonists, weight-loss drugs like Wegovy and Ozempic ...

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

The U.S. Food and Drug Administration (FDA) and drug manufacturer Novo Nordisk are warning consumers about “counterfeit” Ozempic found outside the authorized drug supply chain. The contents of ...